News & Press

Abbisko Therapeutics Announces the Appointment of Mr. Yongyi Li as General Counsel

Jun 04,2021
By Abbisko
Back

4 June, 2021, Shanghai – Abbisko Therapeutics Co., Ltd. (“Abbisko” hereafter) today announced the appointment of Mr. Yongyi Li as General Counsel. He will report to Dr. Yao-Chang Xu, Chairman and CEO of Abbisko.

Mr. Li has many years of experience in both multi-national healthcare & pharmaceutical companies and leading international law firms. During the past eight years prior to joining Abbisko, Mr. Li has served as Vice President and General Counsel for Cardinal Health Asia Pac and Eli Lilly China successively. Mr. Li provided legal counsel which was instrumental to Lilly China’s significant business transformation and rapid growth in the past four years, highlighted by seven successful launches, featuring innovative new products ranging from oncology to immunology and diabetes. Under Mr. Li’s leadership, Lilly China legal team won China Business Law Journal’s Highly Commended Healthcare & Life Sciences Team for the past two years. Prior to moving in-house, Mr. Li worked at White & Case LLP’s New York and Beijing office and Latham & Watkins LLP’s Shanghai office. Before Mr. Li started his legal career, he did research on healthy aging at Duke University Center for Demographic Studies. 
Mr. Li obtained both his Juris Doctor degree and his Master of Arts degree in Sociology from Duke University. He obtained his Bachelor of Science degree from Beijing Science and Technology University. 
“We are pleased to have Mr. Li join Abbisko to start the next stage of his career.” said Mr. Yao-Chang Xu, “Mr. Li is a proven leader with extensive knowledge in strategy and operation, as well as the experience in driving policy change to improve industry ethical codes of conduct. His insights and expertise will facilitate Abbisko to achieve robust and sustained growth.”
"Abbisko is a truly innovative company with extraordinary R&D capability and an impressive management team with great synergy,” Mr. Li said, "I am very excited to join such an excellent team at a time Abbisko accelerates its growth and I look forward to working with our talented colleagues to provide full-spectrum legal and compliance support to ensure sustained growth with integrity and elevate Abbisko to the next level - making a real difference for patients in China and around the globe.”

Tel:(+86) 021-68912098

E-MailL:Public@abbisko.com Bd@abbisko.com

Copyright © 2021 All rights reserved:Abbisko Therapeautics     滬ICP備17056565號-1